Evidence map›Paper›PMID 30158742›Full record

ReviewIndian journal of nephrology

Fluoroquinolones and BK Virus Nephropathy: A Myth or a Reality.

M A M Khalil, M A U Khalil, J Tan, T F T Khan

Open access · diamondAbstract readReview
In one paragraph

Review in Indian journal of nephrology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Common viral infections in kidney transplant recipients.Kidney research and clinical practice · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

M A M KhalilDiaverum Prince Abdul Majeed Renal Centre, Jeddah, Saudi Arabia.
M A U KhalilDepartment of Urology, Institute of Kidney Disease, Peshawar, KPK, Pakistan.
J TanDepartment Nephrology, RIPAS Hospital, Bander Seri Begawan, Brunei Darussalam.
T F T KhanDepartment of Nephrology and Transplantation, King Salman Armed Forces Hospital, Tabuk, Saudi Arabia.
Kidney Centre · PKArmed Forces Hospital · SARaja Isteri Pengiran Anak Saleha Hospital · BN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BK polyomavirus (BKV) is a challenging problem for the transplant nephrologist. Various strategies have been used to prevent or treat BK virus nephropathy (BKVN). These include reduction in immunosuppression, intravenous immune globulin, cidofovir, leflunomide, and the fluoroquinolone antibiotics. All these agents have their own toxicities. Great interest was shown to use fluoroquinolones to prevent BKVN after its useful experience was reported in bone marrow transplant. Fluoroquinolones being cheap and easily available, attracted nephrologists to use it, for prevention of BKVN. These agents have been shown

Indexed as

BK polyomavirusBK virus nephropathyfluoroquinolones

Identifiers

PMID30158742
PMCPMC6094829
OpenAlexW2885018685

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.